BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4910027)

  • 1. [Fibrocystic mastopathy and female breast carcinoma: histochemical correlations. 3. Fluoroscopic and immunofluoroscopic studies].
    Barbolini G; Pozzi F; Bignardi P; Pagnotta W
    Arch De Vecchi Anat Patol; 1968 Dec; 54(1):359-76. PubMed ID: 4910027
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrocystic mastopathy and female breast carcinoma: histochemical correlations. II. Proteins].
    Pozzi F; Bignardi P; Botticelli A; Barbolini G
    Arch De Vecchi Anat Patol; 1968 Dec; 54(1):341-57. PubMed ID: 5744076
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast.
    Hilf R; Wittliff JL; Rector WD; Savlov ED; Hall TC; Orlando RA
    Cancer Res; 1973 Sep; 33(9):2054-62. PubMed ID: 4353478
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of cellular DNA in the study of the relations between fibrocystic disease of the breast and breast cancer].
    Lazzari G; Lamarca S
    Arch Sci Med (Torino); 1977; 134(2):137-44. PubMed ID: 869700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrocystic mastopathy and carcinoma of the female breast: histochemical correlations. I. The polysaccharides].
    Botticelli A; Barbolini G; Bignardi P; Pagnotta W
    Arch De Vecchi Anat Patol; 1967 Oct; 49(3):811-54. PubMed ID: 5606011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibility of using histo- and cytochemical determination of phosphorylase in the diagnosis of breast tumors].
    Probatova NA; Koriakina RF
    Arkh Patol; 1967; 29(2):18-22. PubMed ID: 4302650
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antioxidative activity of breast tissue in fibroadenoma, fibrocystic mastopathy and cancer].
    Pal'mina NP; Burlakova EB; Kal'nova NIu
    Vopr Onkol; 1978; 24(10):70-6. PubMed ID: 716321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycosaminoglycan (GAG) content and GAG electropherogram pattern of breast tumors and chronic fibrous mastopathy].
    Sehrt B; Mangakis N
    Arch Geschwulstforsch; 1982; 52(6):459-68. PubMed ID: 7159184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on stromal component of mastopathy--content and type of collagen].
    Okano F
    Hokkaido Igaku Zasshi; 1985 Jul; 60(4):555-70. PubMed ID: 2997011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histochemical studies of proteins, SH and NH 2 groups in infiltrating breast carcinoma].
    Nowak HF; Jodczyk JK; Cylwik B
    Patol Pol; 1972; 23(3):317-25. PubMed ID: 5072523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of the "toxohormone" activity of extracts of mammary carcinoma and fibrocystic mastopathy].
    Guarino M; Giarrusso AM; Mascitelli Coriandoli E
    Quad Clin Ostet Ginecol; 1964 Dec; 19(12):1235-43. PubMed ID: 5882260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the importance of fibrocystic mastopathy as a precancerous lesion].
    Napolitano A; Di Curzio B; Stella S
    Ann Ital Chir; 1973-1974; 48(3-4):265-76. PubMed ID: 4378000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anatomo--surgical data on fibrocystic mastopathy].
    Teramo A; Ruggiero A; Sica GS
    G Ital Chir; 1970; 26(1):65-83. PubMed ID: 5519876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
    Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
    Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease.
    Minton JP; Foecking MK; Webster DJ; Matthews RH
    Am J Obstet Gynecol; 1979 Sep; 135(1):157-8. PubMed ID: 224703
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of immunohistochemical probes in the study of benign and malignant breast disease.
    Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
    Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical evaluation of fibrocystic mastopathy. (Actuarial statistical study)].
    Ciuffini F; Consolandi G
    Acta Chir Ital; 1966; 22(5):499-526. PubMed ID: 5994397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mastopathy and breast cancer].
    Berndt H; Marwitz S
    Arch Geschwulstforsch; 1968; 32(1):137-48. PubMed ID: 5692645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.